Tevogen Bio Holdings Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Tevogen Bio Holdings Inc. reported Cash And Cash Equivalents At Carrying Value of $129.2 thousand for the year ending 2022.

  • Tevogen Bio Holdings Inc. showed a decrease of -62.5% in Cash And Cash Equivalents At Carrying Value from 2021 to 2022.
  • This data is from Tevogen Bio Holdings Inc.'s annual report (Form 10-K), filed with the SEC on April 17, 2023.
  • XBRL data for this metric is available from 2021 to 2022 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2022: $231.5 thousand | Q2 2022: $185.6 thousand | Q3 2022: $143.0 thousand.
  • Historical annual values: Fiscal year 2022: $129.2 thousand | Fiscal year 2021: $344.6 thousand.
  • Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: